Frontiers in Immunology · 2018 · 39 citations · 49 references
Life SciencesImmunologyPathologyAutoimmunityCellular ImmunologyImmunopathologyAutoimmune Disease PathogenesisAutoimmune Disease PathologyAutoimmune DiseasesAutoimmune InflammationAutoimmune PathogenesisImmune-mediated DiseaseBone Marrow - Derived CellsEndogenous Antigen PresentationMonocyte InfiltrationMonocyte TraffickingSelf-antigen PresentationT-cell Mediated AutoimmunityT-cell Mediated Myocardial InflammationTh17 Cell Differentiation
Autoimmune myocarditis often leads to dilated cardiomyopathy. Although T cell reactivity to cardiac self-antigen is common in the disease, it is unknown which antigen presenting cell (APC) triggers autoimmunity. Experimental autoimmune myocarditis (EAM) was induced by immunizing mice with α-myosin loaded bone marrow APCs cultured in GM-CSF. APCs found in such cultures include conventional type 2 CD11b+ cDCs (GM-cDC2s) and monocyte-derived cells (GM-MCs). However, only α-myosin loaded GM-cDC2s could induce EAM. We also studied antigen presenting capacity of endogenous type 1 CD24+ cDCs (cDC1s), cDC2s and MCs for α-myosin-specific TCR-transgenic TCR-M CD4+ T cells. After EAM induction, all cardiac APCs significantly increased and cDCs migrated to the heart-draining mediastinal lymph node. Primarily cDC2s presented α-myosin to TCR-M cells and induced Th1/Th17 differentiation. Loss of IRF4 in Irf4fl/fl.Cd11cCre mice reduced MHCII expression on GM-cDC2s in vitro and cDC2 migration in vivo. However, partly defective cDC2 functions in Irf4fl/fl.Cd11cCre mice did not suppress EAM. MCs were the largest APC subset in the inflamed heart and produced pro-inflammatory cytokines. Targeting APC populations could be exploited in the design of new therapies for cardiac autoimmunity.
49
Differential Antigen Processing by Dendritic Cell Subsets in Vivo
Diana Dudziak, Alice O. Kamphorst, Gordon F. Heidkamp et al. · Science · 2007 · 1.4K citations · Full text